X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. RXRX

Go back to X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 1c

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

March 4, 2021 8:00 AM EST

2021 expected to be a year of key value-driving catalysts as company advances multiple clinical programs with lead candidate mavorixafor

Company anticipates completing full enrollment in WHIM Phase 3 trial in 2021 and presenting clinical data from the ongoing Phase 1b Waldenströms trial throughout the year

Conference call today at 8:30 a.m. ET

BOSTON, March 04, 2021 (GLOBE NEWSWIRE) --... More